Global Peptide Therapeutics Market Insights, Forecast to 2025

  • ID:PD003887
  • September 2019
  • QY Research
                          

Peptide Therapeutics Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Peptide Therapeutics Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Peptide Therapeutics market.
 
This research report categorizes the global Peptide Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
 
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
 
In this report, we study the peptide-based drugs.In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
 
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
 
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
 
In 2017, the global Peptide Therapeutics market size was 28500 million US$ and is forecast to 37400 million US in 2025, growing at a CAGR of 3.5% from 2018. The objectives of this study are to define, segment, and project the size of the Peptide Therapeutics market based on company, product type, application and key regions.
 
The various contributors involved in the value chain of Peptide Therapeutics include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Peptide Therapeutics include

  • Sanofi
  • Teva
  • Novo Nordisk
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Novartis
  • Shire
  • AbbVie
  • Ipsen
  • Allergan
  • Ferring
  • Merck
  • The Medicines
  • Roche
  • J & J
Market Size Split by Type
  • Injection
  • Oral
  • Other
Market Size Split by Application
  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other
Market size split by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa
The study objectives of this report are:
  • To study and analyze the global Peptide Therapeutics market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
  • To understand the structure of Peptide Therapeutics market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Peptide Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Peptide Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To project the value and volume of Peptide Therapeutics submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents - Guidelines
1 Study Coverage
1.1  Peptide Therapeutics Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Peptide Therapeutics Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Oral
1.4.4 Other
1.5 Market by Application
1.5.1 Global Peptide Therapeutics Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Metabolic Disorders
1.5.4 Central Nervous System
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Peptide Therapeutics Market Size
2.1.1 Global Peptide Therapeutics Revenue 2016-2025
2.1.2 Global Peptide Therapeutics Sales 2016-2025
2.2 Peptide Therapeutics Growth Rate by Regions
2.2.1 Global Peptide Therapeutics Sales by Regions
2.2.2 Global Peptide Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Peptide Therapeutics Sales by Manufacturers
3.1.1 Peptide Therapeutics Sales by Manufacturers
3.1.2 Peptide Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peptide Therapeutics Revenue by Manufacturers
3.2.1 Peptide Therapeutics Revenue by Manufacturers (2016-2018)
3.2.2 Peptide Therapeutics Revenue Share by Manufacturers (2016-2018)
3.3 Peptide Therapeutics Price by Manufacturers
3.4 Peptide Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Peptide Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peptide Therapeutics Product Category
3.4.3 Date of International Manufacturers Enter into Peptide Therapeutics  Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Peptide Therapeutics Sales by Type
4.2 Global Peptide Therapeutics Revenue by Type
4.3 Peptide Therapeutics Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Peptide Therapeutics Breakdown Data by Application
6 North America
6.1 North America Peptide Therapeutics by Countries
6.1.1 North America Peptide Therapeutics Sales by Countries
6.1.2 North America Peptide Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Peptide Therapeutics by Type
6.3 North America Peptide Therapeutics by Application
6.4 North America Peptide Therapeutics by Company
7 Europe
7.1 Europe Peptide Therapeutics by Countries
7.1.1 Europe Peptide Therapeutics Sales by Countries
7.1.2 Europe Peptide Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Peptide Therapeutics by Type
7.3 Europe Peptide Therapeutics by Application
7.4 Europe Peptide Therapeutics by Company
8 Asia Pacific
8.1 Asia Pacific Peptide Therapeutics by Countries
8.1.1 Asia Pacific Peptide Therapeutics Sales by Countries
8.1.2 Asia Pacific Peptide Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Peptide Therapeutics by Type
8.3 Asia Pacific Peptide Therapeutics by Application
8.4 Asia Pacific Peptide Therapeutics by Company
9 Central & South America
9.1 Central & South America Peptide Therapeutics by Countries
9.1.1 Central & South America Peptide Therapeutics Sales by Countries
9.1.2 Central & South America Peptide Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Peptide Therapeutics by Type
9.3 Central & South America Peptide Therapeutics by Application
9.4 Central & South America Peptide Therapeutics by Company
10 Middle East and Africa
10.1 Middle East and Africa Peptide Therapeutics by Countries
10.1.1 Middle East and Africa Peptide Therapeutics Sales by Countries
10.1.2 Middle East and Africa Peptide Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Peptide Therapeutics by Type
10.3 Middle East and Africa Peptide Therapeutics by Application
10.4 Middle East and Africa Peptide Therapeutics by Company
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.1.4 Peptide Therapeutics Product Description
11.1.5 Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.2.4 Peptide Therapeutics Product Description
11.2.5 Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.3.4 Peptide Therapeutics Product Description
11.3.5 Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.4.4 Peptide Therapeutics Product Description
11.4.5 Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.5.4 Peptide Therapeutics Product Description
11.5.5 Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.6.4 Peptide Therapeutics Product Description
11.6.5 Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.7.4 Peptide Therapeutics Product Description
11.7.5 Recent Development
11.8 Shire
11.8.1 Shire Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.8.4 Peptide Therapeutics Product Description
11.8.5 Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.9.4 Peptide Therapeutics Product Description
11.9.5 Recent Development
11.10 Ipsen
11.10.1 Ipsen Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Peptide Therapeutics
11.10.4 Peptide Therapeutics Product Description
11.10.5 Recent Development
11.11 Allergan
11.12 Ferring
11.13 Merck
11.14 The Medicines
11.15 Roche
11.16 J & J
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Peptide Therapeutics Raw Material
13.1.2 Peptide Therapeutics Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..